|
Re: Metformin, anything new?
I did some very prelinary research. That study showing only ER postive patients apparently was done in patients who also had diabetes. The concurrent diabetes may have an an influence.
There was an article in the journal Biomed Research International Volume 2015 written in Oct 2014. It was fairly long and I just skimmed through it. There was one long sentence that I found intersting: "In vitro studies strongly support the role for Metformin in the treatment for most if not all of the subtypes of breast cancer especially the hard to treat Triple Negative Breast Cancer.
The anti-cancer effect of Metformin in TNBC cells is in the test tube so we cant say the actual effect in treatment. Still in theory, Metformin should be useful. Ill resarch this further as today I only skimmed through it. M aybe there will be something more substantial. I dont understand the doctors ending the Metformin prescriptions based on one study when there seem to be others that contradict the results.
Paul
|